Form 4 Filing for APOGEE ENTERPRISES, INC.

This filing details a Form 4 submission for APOGEE ENTERPRISES, INC. (APOG) concerning the acquisition of 41 Deferred Restricted Stock Units by director Elizabeth Murphy Lilly. These units, granted under the 2019 Non-Employee Director Stock Plan, will be settled in common stock upon the director's termination from the Board or other specified events. The acquisition occurred on June 30, 2026, with a transaction price of $45.74 per share. Following this transaction, Ms. Lilly holds 9,682 shares in total. The filing also notes that additional units were allocated due to a dividend equivalent reinvestment feature. The transaction code 'A' indicates an acquisition, and the ownership nature is direct ('D'). The settlement is on a 1-for-1 basis.